iA Global Asset Management’s Biogen BIIB Stock Holding History

iA Global Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,978	Closed	-$2.38M	–	402
2025 Q3	$2.38M	Buy	16,978 +754	+5%	+$102K	0.03%	243
2025 Q2	$2.04M	Sell	16,224 -2,118	-12%	-$264K	0.03%	239
2025 Q1	$2.51M	Buy	18,342 +2,636	+17%	+$377K	0.04%	216
2024 Q4	$2.4M	Buy	15,706 +858	+6%	+$145K	0.04%	219
2024 Q3	$2.88M	Buy	14,848 +545	+4%	+$114K	0.05%	216
2024 Q2	$3.32M	Buy	14,303 +645	+5%	+$140K	0.06%	187
2024 Q1	$2.94M	Buy	13,658 +627	+5%	+$147K	0.06%	203
2023 Q4	$3.37M	Buy	13,031 +960	+8%	+$236K	0.08%	185
2023 Q3	$3.1M	Buy	12,071 +3,145	+35%	+$841K	0.08%	186
2023 Q2	$2.54M	Buy	+8,926	New	+$2.66M	0.07%	207

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

iA Global Asset Management's BIIB Position: Q4 2025 in Review

iA Global Asset Management sold out of Biogen (BIIB) in Q4 2025, closing a stake of 16,978 shares — an estimated $2.38M sold.

iA Global Asset Management first reported a position in BIIB in Q2 2023 and held it in 10 quarters. The position peaked at $3.37M in Q4 2023. 1,000 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

iA Global Asset Management reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
iA Global Asset Management sold 16,978 Biogen shares in Q4 2025, an estimated $2.38M.
iA Global Asset Management first reported a position in Biogen in Q2 2023 and held it in 10 quarters.
iA Global Asset Management's Biogen position peaked at $3.37M in Q4 2023.
1,000 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on iA Global Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.